1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Arata Corporation

Arata Corporation

TTSE:2733
2,659.00
JPY
+71.00
(+2.74%)
99.29BMarket Cap
Nov 10Next Earn
Arata Corporation
TSE:2733
(Tokyo Stock Exchange)

Recent

price

2,659.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
20,035.31
19,672.41
19,986.48
21,143.45
20,719.82
21,949.37
23,974.48
22,991.22
21,731.97
22,865.63
24,439.81
25,096.25
26,105.98
27,716.1
29,473.06
30,029.4
- -
Revenue per Share
33.78
52.79
57.33
78.97
36.46
105.22
165.46
199.54
198.84
206.51
240.29
263.79
240.77
303.01
309.55
302.76
- -
Basic EPS, GAAP
-41.27
-154.28
198.33
-159.11
473.27
136.29
324.53
205.82
180.75
51.09
256.05
1.35
194.24
248.03
108
303.93
- -
Free Cash Flow per Basic Share
12.55
17.44
19.98
20.01
25.01
37.98
30.96
34.54
40.01
40.69
45.98
55.08
66.82
77.21
104.27
110.22
- -
Dividend per Share
1,480.01
1,533.89
1,589.71
1,654.58
1,748.14
1,813.77
2,027.21
2,142.68
2,273.37
2,430.6
2,666.33
2,815.62
2,988.44
3,252.24
3,490.49
3,707.89
- -
Book Value per Share
1,333.75
1,395.92
1,456.49
1,515.48
1,613.63
1,691.13
1,905.59
2,037.88
2,170.03
2,321.92
2,555.62
2,687.17
2,841.75
3,086.05
3,320.22
3,246.5
- -
Tangible Book Value per Share
30
31
31
31
31
31
29
32
35
35
34
34
34
34
33
33
33
Basic Weighted Avg Shares
601,949
606,705
616,327
651,954
638,792
676,743
704,610
732,914
754,447
796,227
834,033
857,087
891,600
944,149
986,212
1,004,749
- -
Sales/Revenue/Turnover
0.05
0.69
0.6
0.69
0.39
0.84
1.05
1.21
1.18
1.17
1.38
1.49
1.44
1.54
1.52
1.31
- -
Operating Margin (%)
3,607
3,767
4,054
4,406
4,748
4,957
4,675
4,360
4,462
4,288
4,297
4,522
4,604
4,610
4,768
4,862
- -
Depreciation Expense
1,015
1,628
1,768
2,435
1,124
3,244
4,863
6,361
6,903
7,191
8,200
9,009
8,223
10,322
10,358
10,130
- -
Net Income, GAAP
67.9
56.11
50.01
48.49
55.22
43.19
35.09
34.28
31.95
32.52
32.64
32.03
36.37
31.9
33.65
31.35
- -
Effective Tax Rate (%)
0.17
0.27
0.29
0.37
0.18
0.48
0.69
0.87
0.91
0.9
0.98
1.05
0.92
1.09
1.05
1.01
- -
Profit Margin (%)
21,681
27,222
29,291
35,105
21,492
22,117
29,452
25,425
45,327
45,505
50,946
54,512
58,921
72,098
74,744
77,779
- -
Working Capital
24,331
29,042
30,904
38,048
27,157
24,215
27,930
14,648
21,861
18,981
18,803
19,266
17,453
23,757
22,879
31,543
- -
LT Debt
45,665
47,323
49,042
51,040
53,910
55,941
59,611
71,470
80,513
82,898
91,015
96,170
102,064
109,718
116,556
124,161
- -
Total Equity
0.08
1.57
1.57
1.89
0.9
2.73
4.04
4.88
4.97
5.06
6.01
6.42
5.7
6.6
6.48
5.4
- -
Return on Invested Capital (%)
1.19
1.73
1.84
2.32
1.18
3.04
4.41
5.61
5.89
5.98
6.57
6.91
5.93
7.16
7.07
6.41
- -
Return on Capital (%)
2.25
3.5
3.67
4.87
2.14
5.91
8.42
9.71
9.09
8.8
9.43
9.63
8.3
9.75
9.16
8.42
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
10,982
22,193
- -
LT Borrowings
28,396
27,576
- -
LT Finance Leases
- -
3,967
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
33
33
34
Market Capitalization
103,948
99,292
83,774

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
246,666
256,312
- -
Cash, Cash Equivalents & STI
27,095
39,710
- -
Accounts Receivable, Net
130,208
129,370
- -
Inventories
47,140
46,627
- -
Total Current Liabilities
161,392
178,533
- -
Payables & Accruals
- -
- -
- -
ST Debt
10,982
22,193
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.39%
6.41%
6.52%
Free Cash Flow
1,478.47%
2,874.76%
181.38%
Net Income, GAAP
13.23%
4.97%
-2.2%
Sales/Revenue/Turnover
4.04%
3.8%
1.88%
Total Cash Common Dividend
13.24%
18.96%
5.7%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
986,212
2026
- -
- -
- -
- -
1,004,749
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
309.55
2026
- -
- -
- -
- -
302.76
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
104.27
2026
- -
- -
- -
- -
110.22
2027
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
ARATA Corporation (TSE: 2733) operates as a leading wholesaler of daily necessities, cosmetics, household products and pet supplies in Japan. The company wholesales an extensive range of health and beauty products, including cosmetics, shampoos, soaps, bath additives, oral care items and pharmaceuticals; household detergents such as laundry, dishwashing and kitchen cleaners; home care products comprising insecticides, air fresheners, deodorizers and batteries; paper products like tissues, toilet paper and disposable diapers; household goods including kitchen supplies, cleaning equipment, cooking utensils, sponges and scrubbing brushes; and pet supplies encompassing pet food, accessories, grooming services and related retail operations. ARATA maintains a nationwide logistics network spanning Hokkaido to Kyushu, delivering daily to approximately 3,500 retailers such as drugstores, home improvement centers, supermarkets, discount stores, general merchandise stores and e-commerce operators, while sourcing from around 1,200 manufacturers. Founded on April 1, 2002, and headquartered at East 21 Tower, 6-3-2 Toyo, Koto-ku, Tokyo, Japan, ARATA conducts operations primarily in Japan with international subsidiaries in China, Thailand and Vietnam, including ARATA (THAILAND) CO., LTD., ARATA VIETNAM COMPANY LIMITED and XIN LE HUA (GUANGZHOU) INTERNATIONAL TRADING CO., LTD. Recent developments include a July 2025 logistics collaboration with PALTAC Corporation; a May 2025 announcement of an absorption-type merger with wholly owned subsidiary Living Arata Co., Ltd. alongside revisions to FY03/26 numerical targets under the Medium-term Management Plan 2026; a January 2024 2-for-1 stock split to enhance liquidity and investor base; and the establishment of a new Guangzhou subsidiary in January 2024.